BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6895435)

  • 1. [The effect of molsidomin on the arterial windkessel (author's transl)].
    Sauer G; Tebbe U; Krause H; Kreuzer H; Neuhaus KL
    Z Kardiol; 1981 Sep; 70(9):713-8. PubMed ID: 6895435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Action of molsidomine on haemodynamics at rest and on exercise in patients who have coronary heart disease (author's transl)].
    Niehues B; Krimmel W; Hombach V; Tauchert M; Behrenbeck DW; Hilger HH
    Dtsch Med Wochenschr; 1978 May; 103(20):853-6. PubMed ID: 648365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of molsidomin on left ventricular function and volume in patients with coronary heart disease (author's transl)].
    Karsch KR; Blanke H; Kreuzer H; Rentrop KP
    Z Kardiol; 1979 Feb; 68(2):71-6. PubMed ID: 425616
    [No Abstract]   [Full Text] [Related]  

  • 4. Molsidomine in the treatment of patients with angina pectoris.
    Majid PA; DeFeyter PJ; Van der Wall EE; Wardeh R; Roos JP
    N Engl J Med; 1980 Jan; 302(1):1-6. PubMed ID: 6985697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An improved exercise test in coronary-heart disease: effect of molsidomin on erogometrically controlled exercise (author's transl)].
    Blazek G; Heeger H; Kubicek F
    Dtsch Med Wochenschr; 1977 Jan; 102(3):81-4. PubMed ID: 832584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of molsidomine on left ventricular function in coronary heart disease (author's transl)].
    Meyer J; Sprauer R; Krebs W; Erbel R; Schweizer P; Effert S
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1210-6. PubMed ID: 6893579
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of the anti-angina drug korvatone (molsidomin) and organic nitrates].
    Komarov FI; Ol'binskaia LI; Vartanova OA; Bragina GI; Ovchinnikova LV
    Klin Med (Mosk); 1980 Aug; 58(8):55-60. PubMed ID: 6774161
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamic actions of molsidomin in coronary artery disease. Effects on regional myocardial blood flow, segmental ventricular wall motion, ejection phase parameters, ventricular volumes, systemic and pulmonary artery pressures and cardiac output (author's transl)].
    Fleck E; Dirschinger J; Rudolph W
    Herz; 1979 Jun; 4(3):285-92. PubMed ID: 457027
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative examinations of the effectiveness of Molsidomin and nitrates in angina pectoris].
    Lehmann HU; Ziegler G; Hochrein H
    Med Welt; 1980 Jul; 31(29-30):1099-103. PubMed ID: 6774198
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
    Beloev I; Tomov I; Elenkova A; Terzieva L
    Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of molsidomine on global and regional left ventricular function at rest and during exercise in patients with angina pectoris.
    Nechwatal W; Stauch M; Sigel H; Kress P; Bitter F; Geffers H; Adam WE
    Clin Cardiol; 1981; 4(5):248-53. PubMed ID: 6895491
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of molsidomine on hemodynamics for the patients with chronic heart failure (author's transl)].
    Hayasaki K; Tokunaga M; Kodama H; Kikuchi H; Matsunaga K; Ogata A; Ogawa T
    Kokyu To Junkan; 1981 Mar; 29(3):305-10. PubMed ID: 6894802
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of korvatone on hemodynamics in the acute stage of myocardial infarct].
    Belov Iu; Daskalov T; Chichovski K; Kusitasev G; Popnikolov S
    Vutr Boles; 1981; 20(5):70-80. PubMed ID: 6895680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molsidomine in ergometric tests (author's transl)].
    Röhl D; Lehmann KH
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1216-9. PubMed ID: 6893580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of nitroglycerin and molsidomine. Effects on the integrated systemic venous bed and the arterial pressure in dogs.
    Grund E; Müller-Ruchholtz ER; Lapp ER; Lösch HM; Lochner W
    Arzneimittelforschung; 1978; 28(9):1624-8. PubMed ID: 113018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of molsidomine.
    Rakovec P
    J Cardiovasc Pharmacol; 1980; 2(6):893-4. PubMed ID: 6160337
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anti-ischemic effect of 8 mg molsidomin in retard form].
    Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with molsidomin].
    Schlimmer P
    ZFA (Stuttgart); 1980 Mar; 56(9):610-1. PubMed ID: 7376699
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of molsidomine on cardiac function in experimental transitory coronary insufficiency].
    Litvitskiĭ PF; Ol'binskaia LI; Sandrikov VA; Aksiuk MA
    Kardiologiia; 1981 Apr; 21(4):71-4. PubMed ID: 6894773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.